2007/042a Updated: NICE responds to judicial review outcome
Commenting on today's ruling, NICE Chief Executive, Andrew Dillon said: “The legal challenge to our recommendation that drugs for Alzheimer's disease should only be prescribed to those in the moderate stage of the disease has failed. We were challenged on six grounds, and the court found in our favour on five of them. This ruling strengthens NICE by endorsing our approach to evaluating drugs."
 |
2007/042a Updated: NICE responds to judicial review outcome 10 August 2007 (37.1Kb 13sec @ 28.8Kbps) |
This page was last updated: 13 November 2007
